Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.
Neil R ParikhClaudia HuizaJill S PatelSonny TsaiNathisha KalpageMay TheinSage PitcherSteve P LeeWarren S InouyeMark L JordanHomayoon SanatiLida JafariCarol J BennettGreg E GinAmar U KishanRobert E ReiterMichael LewisAhmad SadeghiWilliam J AronsonIsla P GarrawayMatthew B RettigNicholas G NickolsPublished in: BMC cancer (2019)
Clinicaltrials.gov identifier: NCT03298087 (registration date: September 29, 2017).